Working… Menu

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00253201
Recruitment Status : Completed
First Posted : November 15, 2005
Last Update Posted : May 18, 2011
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.